|4Mar 23, 7:23 PM ET

Daruwala Paul 4

4 · Cidara Therapeutics, Inc. · Filed Mar 23, 2020

Insider Transaction Report

Form 4
Period: 2020-03-19
Daruwala Paul
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2020-03-19+90,00090,000 total
    Exercise: $1.98Exp: 2030-03-18Common Stock (90,000 underlying)
Footnotes (1)
  • [F1]The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 19,2020.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION